CHADS(2) and CHA(2)DS(2)-VASc Scores Can Guide the Evaluation of Cryptogenic Ischemic Stroke

Abstract

Background and Aims: Cryptogenic ischemic strokes (CIS) are treated with antiplatelets for stroke prevention in routine clinical practice. The objective of this study was to investigate whether the CHADS(2) and CHA(2)DS(2)-VASc scores may be used to identify the patients with CIS at higher risk of ischemic stroke despite antiplatelet therapy.